Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach
Wirichada Pan–ngum(Mahidol University), Lisa J. White(University of Oxford), Sompob Saralamba(Mahidol University), Timothy Kinyanjui(University of Manchester), Moses C. Kiti(Kenya Medical Research Institute), Jean‐François Toussaint(Université Paris Cité), D. James Nokes(Kenya Medical Research Institute), Sylvia Taylor(GlaxoSmithKline (Belgium)), Thierry Van Effelterre(Johnson & Johnson (United States))
Cited by 41
Related Papers
Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments
|Journal of Virological Methods|2006|342
Bluetongue in northern Europe
|Veterinary Record|2006|157
Reproducibility of High-Resolution MRI for the Identification and the Quantification of Carotid Atherosclerotic Plaque Components
|Stroke|2007|126
The Citius End: World Records Progression Announces the Completion of a Brief Ultra-Physiological Quest
|PLoS ONE|2008|121
Water Diffusion Properties of Human Atherosclerosis and Thrombosis Measured by Pulse Field Gradient Nuclear Magnetic Resonance
|Arteriosclerosis Thrombosis and Vascular Biology|1997|119